Heart Failure Clinical Trial

Heart Failure and Peritoneal Ultrafiltration

Summary

The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory quality of life in comparison to patients who remain on standard therapy alone.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adults with congestive heart failure (CHF) who remain fluid overloaded despite standard treatment.

Exclusion Criteria:

Patients who have reversible CHF or have diseases or conditions that would contraindicate the use of peritoneal dialysis.

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

12

Study ID:

NCT00368641

Recruitment Status:

Terminated

Sponsor:

Baxter Healthcare Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You


San Jose California, , United States

Torrance California, , United States

Denver Colorado, , United States

Evanston Illinois, , United States

Winston-Salem North Carolina, , United States

Melbourne Victoria, , Australia

Leuven , , Belgium

Liege , , Belgium

Roeselare , , Belgium

Toronto Ontario, , Canada

Montreal Quebec, , Canada

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

12

Study ID:

NCT00368641

Recruitment Status:

Terminated

Sponsor:


Baxter Healthcare Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider